SCHEMBL122166

SCHEMBL122166

O=C(O)C1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1527305 1.00
SCHEMBL20296 1.00
Methane SCHEMBL27771786 0.97
Ammonia Solution, Strong SCHEMBL31008744 0.97
Hydrochloric Acid SCHEMBL3623568 0.97
Hydrochloric Acid SCHEMBL3540925 0.97
SCHEMBL17743461 0.97
Hydrochloric Acid SCHEMBL3540927 0.97
SCHEMBL8077380 0.92 MEN1 (0.46)
Acetic Acid SCHEMBL4726910 0.92 MEN1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6811 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4127157-B1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS ENCODIA INC (US) 2026-02-11 EP claimed
US-12521455-B2 Kisspeptin receptor (KISS1R) targeted therapeutics and uses thereof RADIONETICS ONCOLOGY, INC. (US) 2026-01-13 US claimed
EP-4652183-A1 PEPTIDE-DRUG CONJUGATES FOR TARGETED THERAPY OF RENAL DISEASES Shanghai MicuRx Pharmaceutical Co., Ltd. (CN) 2025-11-26 EP claimed
US-20250339569-A1 CARBONIC ANHYDRASE IX LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-11-06 US claimed
WO-2025217074-A1 KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF RADIONETICS ONCOLOGY, INC. (US) 2025-10-16 WO claimed
US-20250312499-A1 KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF RADIONETICS ONCOLOGY, INC. 2025-10-09 US claimed
US-12428447-B2 Peptide-based non-proteinaceous cargo delivery FELDAN BIO INC. (CA) 2025-09-30 US claimed
US-20250145644-A1 PROCESSES AND COMPOUNDS FOR PREPARING SPIROLIGOMERS TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2025-05-08 US claimed
EP-4541891-A1 NOVEL LRP1-BINDING PEPTIDE Ichimaru Pharcos Co., Ltd. (JP) 2025-04-23 EP claimed
US-20250109171-A1 COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL DISEASES Shanghai MICURX Pharmaceuticals Co., Ltd. (CN) 2025-04-03 US claimed
EP-0078191-B1 COLLAGEN INHIBITING COMPOSITIONS AND PROCESSES FOR MANUFACTURING AND USING THE SAME UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 1986-09-03 EP claimed
EP-0142387-A1 Process for the preparation of vaccines specific for LH and HCG and process for their detection ANDA BIOLOGICALS (FR) 1985-05-22 EP claimed
WO-1984003507-A1 ENZYME INHIBITION FERRING AB (SE) 1984-09-13 WO claimed
EP-0118280-A1 Enzyme inhibition Aktiebolaget Hässle (SE) 1984-09-12 EP claimed
US-4455372-A SERRATIA MARCESCENS TANABE SEIYAKU CO., LTD. (JP) 1984-06-19 US claimed
US-4428939-A POLYMERIC HYDROXYPROLINE FOR REDUCTION OF SCAR TISSUE COLLEGE OF MEDICINE AND DENTISTRY OF NEW JERSEY 1984-01-31 US claimed
EP-0029265-B1 A METHOD FOR PREPARING AZETIDINE DERIVATIVES, MALE STERILITY IN PLANTS PRODUCING COMPOSITIONS CONTAINING THEM, THEIR USE IN STERILIZING MALE PARTS IN PLANTS, A METHOD OF PRODUCING F1 HYBRID SEED AND CERTAIN NOVEL AZETIDINE DERIVATIVES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1983-08-17 EP claimed
EP-0078191-A2 Collagen inhibiting compositions and processes for manufacturing and using the same UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 1983-05-04 EP claimed
EP-0076516-A2 Method for fermentative production of L-proline Tanabe Seiyaku Co., Ltd. (JP) 1983-04-13 EP claimed
US-4105696-A Asymmetric synthesis of organic compounds HOFFMANN-LA ROCHE INC. (US) 1978-08-08 US claimed